Lipoproteins and β-Cell Functions: From Basic to Clinical Data

Por Lee, Dae Ho
Publicado em 2014

Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Databa...

Por Lee, Dae Ho
Publicado no Diabetes Metab J (2015)

Second-generation anaplastic lymphoma kinase inhibitors: revolutionary or evolutionary?

Por Lee, Dae Ho
Publicado no J Thorac Dis (2016)

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era

Por Lee, Dae Ho
Publicado no ESMO Open (2018)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease

Por Lee, Dae Ho
Publicado no Endocrinol Metab (Seoul) (2020)

Update of early phase clinical trials in cancer immunotherapy

Por Lee, Dae Ho
Publicado no BMB Rep (2021)

A personalized channel recommendation and scheduling system considering both section video clips and full video clips

Por Lee, SeungGwan, Lee, DaeHo
Publicado no PLoS One (2018)

Osimertinib, the winner, but cannot yet take it all

Por Yoon, Shinkyo, Kang, Jihoon, Lee, Dae Ho
Publicado no Ann Transl Med (2018)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors

Por Kim, Na-Hyung, Yu, Taeyang, Lee, Dae Ho
Publicado em 2014

Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations

Por Yoon, Shinkyo, Lee, Dae Ho, Kim, Sang-We
Publicado no Ann Transl Med (2017)

Comments on the trial of cisplatin and etoposide plus thoracic radiotherapy followed by nivolumab or placebo for locally advanced non-small cell lung cancer (RTOG 3505)

Por Yoon, Shinkyo, Lee, Dae Ho, Kim, Sang-We
Publicado no J Thorac Dis (2017)

RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential

Por Nam, Seungyoon, Kim, Jung Ho, Lee, Dae Ho
Publicado no Front Genet (2019)

Molecular Motor Proteins of the Kinesin Superfamily Proteins (KIFs): Structure, Cargo and Disease

Por Seog, Dae-Hyun, Lee, Dae-Ho, Lee, Sang-Kyoung
Publicado em 2004

Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes...

Por Cho, Eun-Hee, Han, Kyungdo, Kim, Bongseong, Lee, Dae Ho
Publicado no Medicine (Baltimore) (2020)

Gliclazide Does Not Fully Prevent 2-Deoxy-D-Ribose-Induced Oxidative Damage Because It Does Not Restore Glutathione Content in a Pancreatic β-Cell Line

Por Koh, Gwanpyo, Kim, Min-Kyoung, Yang, Eun-Jin, Lee, Dae-Ho
Publicado em 2012

Metabolic actions of Rho-kinase in periphery and brain

Por Huang, Hu, Lee, Dae-Ho, Zabolotny, Janice M, Kim, Young-Bum
Publicado em 2013

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned

Por Lee, Dae Ho, Srimuninnimit, Vichien, Cheng, Rebecca, Wang, Xin, Orlando, Mauro
Publicado no Cancer Res Treat (2015)

Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice

Por Lee, Dae Ho, Huang, Hu, Choi, Kangduk, Mantzoros, Christos, Kim, Young-Bum
Publicado em 2012

Statins and All‐Cause Mortality in Patients Undergoing Hemodialysis

Por Jung, Jaehun, Bae, Gi Hwan, Kang, Minsun, Kim, Soo Wan, Lee, Dae Ho
Publicado no J Am Heart Assoc (2020)

Antihypertensive effect of an enzymatic hydrolysate from Styela clava flesh tissue in type 2 diabetic patients with hypertension

Por Ko, Seok-Chun, Jung, Won-Kyo, Lee, Seung-Hong, Lee, Dae Ho, Jeon, You-Jin
Publicado no Nutr Res Pract (2017)